This blog, written by Rosana Kapeller, CSO of Nimbus Therapeutics, is part of the “From the Trenches” feature of LifeSciVC. Early this week, Intercept Pharmaceuticals announced the much awaited design of their Ph. 3 clinical trial of Obeticholic Acid (OCA) in NASH (non-alcoholic steatohepatitis) with liver fibrosis (here). The trial, named REGENERATE, will be the [...]
By Katie Demeria on November 30, 2015 With a $3 million capital raise underway, a group of VCU alumni and Health Diagnostic Laboratory veterans have launched a startup to find cures for “the worst epidemic you’ve never heard of.” That’s how Rebecca Caffrey describes the two increasingly prevalent liver diseases that her new company, the [...]
By Kira Peikoff On 1/30/16 AT 9:50 AM Sandra C., a special education teacher in New Jersey, didn’t worry too much when her doctor told her to call a liver specialist. Sure, she got fatigued running around with the schoolchildren, and friends sometimes told her she looked green, but in general she felt healthy—she couldn’t [...]
Rebecca Caffrey March 10, 2015 Sanyal Biotechnology will be attending the 2016 International Liver Conference meeting in Barcelona, Spain, from April 13-17. Please stop by our booth on the trade show floor, or contact us in advance to set up a private meeting to discuss your needs.